Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.190
-0.020 (-1.65%)
At close: Apr 28, 2026, 4:00 PM EDT
1.190
0.00 (0.00%)
Pre-market: Apr 29, 2026, 5:11 AM EDT

Actinium Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
374239139271132
Upgrade
Market Cap Growth
3.34%7.94%-71.78%-48.69%104.97%24.94%
Upgrade
Enterprise Value
-9-10-385816251
Upgrade
Last Close Price
1.191.361.265.0810.656.01
Upgrade
PS Ratio
412.22471.41-1719.26263.49115.74
Upgrade
PB Ratio
4.745.421.203.834.081.80
Upgrade
P/TBV Ratio
4.745.421.203.834.081.80
Upgrade
P/FCF Ratio
----32.78-
Upgrade
P/OCF Ratio
----31.40-
Upgrade
EV/Sales Ratio
---722.14157.4644.40
Upgrade
EV/FCF Ratio
----19.59-
Upgrade
Debt / Equity Ratio
0.220.220.050.060.040.00
Upgrade
Debt / FCF Ratio
----0.31-
Upgrade
Net Debt / Equity Ratio
-5.91-5.91-2.18-2.05-1.60-1.05
Upgrade
Net Debt / EBITDA Ratio
1.281.281.701.443.143.13
Upgrade
Net Debt / FCF Ratio
1.881.882.161.57-12.843.69
Upgrade
Asset Turnover
0.000.00-0.000.010.02
Upgrade
Quick Ratio
6.026.028.959.0310.2511.38
Upgrade
Current Ratio
6.206.209.149.2110.4411.66
Upgrade
Return on Equity (ROE)
-166.96%-166.96%-110.63%-94.92%-47.16%-36.74%
Upgrade
Return on Assets (ROA)
-35.21%-35.21%-33.25%-33.17%-21.91%-21.26%
Upgrade
Return on Capital Employed (ROCE)
-82.70%-82.70%-61.30%-71.20%-32.90%-33.90%
Upgrade
Earnings Yield
-91.34%-79.87%-97.29%-35.05%-12.17%-18.71%
Upgrade
FCF Yield
-66.53%-58.18%-84.17%-34.10%3.05%-15.86%
Upgrade
Buyback Yield / Dilution
-3.74%-3.74%-13.03%-10.20%-17.37%-69.51%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.